Neuroimaging Findings in Patients With COVID-19
Condition(s):Neuroimaging; COVID-19Last Updated:February 4, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Neuroimaging; COVID-19Last Updated:February 4, 2021Completed
Condition(s):Neuroimaging; Cognitive Dysfunction; Posterior Reversible Encephalopathy SyndromeLast Updated:December 8, 2021Unknown status
Condition(s):Essential TremorLast Updated:February 24, 2021Active, not recruiting
Condition(s):Transient Ischemic AccidentLast Updated:September 5, 2021Not yet recruiting
Condition(s):Hereditary AtaxiaLast Updated:December 16, 2021Recruiting
Condition(s):Brain Neuroimaging Biomarkers in Huntington DiseaseLast Updated:August 8, 2019Completed
Condition(s):Alzheimer DiseaseLast Updated:May 11, 2017Completed
Condition(s):Alzheimer Disease; Amyloid Beta-Peptides; Risk Assessment; Education; Neuropsychological Tests; NeuroimagingLast Updated:May 5, 2021Unknown status
Condition(s):Expectancy Versus Pharmacotherapy Effect of AdderallLast Updated:December 16, 2019Completed
Condition(s):Lorazepam; NeuroimagingLast Updated:May 27, 2022Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.